Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
We are committed to providing our patients with the most advanced and effective options for managing type 2 diabetes and obesity
Stop accepting that "this is just how it is now." Stop putting off the transformation you deserve
Early human research Small PK/PD research and a limited phase 2 program provide human data but not broad clinical validation
CJC-1295 DAC is a long-acting growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to increase growth hormone (GH) and IGF-1 levels
UHC often only covers Wegovy if the patient: Is requesting treatment for weight loss or appetite suppression Will also implement a lifestyle modification, like dietary restrictions, exercise, behavioral support, or other community programs Has a body mass index (BMI) at or above 30 kg/m for adults or in the 95th percentile for pediatric patients
If a dose is missed, skip the missed dose and take the next dose the following day
US$ 23.25
US$ 28.75
US$ 29.82
US$ 27.92
US$ 20.76
